According to this prognostic model, we found that FSCN1, SLC17A9, and ANKRD13B are oncogenes, and overexpression of these genes represents a poor prognosis, whereas ADCY2 and MAPT are tumor suppressor genes and associated with a better prognosis of ccRCC. The gene discussed is MAPT; the disease is nonpapillary renal cell carcinoma.